Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.

38Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE: To elucidate the factors associated with poor prognosis of LEF-induced lung injury in patients with RA. METHODS: The background and clinical and laboratory features of LEF-induced lung injury were examined and compared between patients who died of and who recovered from it. RESULTS: Among 22 patients who developed LEF-induced lung injury, 9 died of and 13 recovered from it. The patients who died tended to have pre-existing interstitial pneumonia (8/9 vs 6/13, P = 0.07). The loading and maintenance doses, serum concentration of the LEF metabolite A771726 and administration period did not differ between the groups. Patients who died had more frequently hypoxaemia of <60 Torr and mechanical ventilation, and had a high serum CRP level (19.3 +/- 9.4 vs 10.1 +/- 8.1 mg/dl, P = 0.03) and a low albumin level (2.7 +/- 0.6 vs 3.3 +/- 0.5 g/dl, P = 0.03) at the lung injury onset. The peripheral blood lymphocyte count decreased in both groups at the lung injury onset, and it remained low until fatal outcome, in contrast to a re-increase upon recovery (406 +/- 394 vs 1203 +/- 399/microl, P = 0.006). The main histopathological finding in two autopsied patients was diffuse alveolar damage, in contrast to the alveolitis observed in a biopsied patient who recovered. CONCLUSIONS: Pre-existing interstitial pneumonia, extremely high serum CRP and low albumin levels, severe hypoxaemia and mechanical ventilation indicated poor prognosis. Peripheral blood lymphocytopenia developed in association with lung injury, and a sustained low lymphocyte count indicated a fatal outcome.

Cited by Powered by Scopus

Drug-induced interstitial lung disease: A systematic review

257Citations
N/AReaders
Get full text

Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review

231Citations
N/AReaders
Get full text

Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis

178Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sato, T., Inokuma, S., Sagawa, A., Matsuda, T., Takemura, T., Otsuka, T., … Sawada, T. (2009). Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford, England), 48(10), 1265–1268. https://doi.org/10.1093/rheumatology/kep227

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

48%

Professor / Associate Prof. 7

33%

Lecturer / Post doc 4

19%

Readers' Discipline

Tooltip

Medicine and Dentistry 19

70%

Pharmacology, Toxicology and Pharmaceut... 5

19%

Engineering 2

7%

Nursing and Health Professions 1

4%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free